XM does not provide services to residents of the United States of America.
G
G

GenuineParts

News

U.S. stocks weekly: Tap the brakes

RPT-BUZZ-U.S. stocks weekly: Tap the brakes Repeats from Friday with no changes to text. Updates chart ** S&P 500 .SPX snaps six-week winning streak, loses 1% as corporate reports pour in .N ** This as the benchmark index sees another spooky turn ** Dow .DJI also ends six-week string of gains, though Nasdaq Composite .IXIC extends its winning streak to seven weeks ** With this, the composite finally scores a fresh record intraday high ** Benchmark U.S.
A
B
N
Q
S
T
W
L
T
G
U
U
H
G
U

U.S. stocks weekly: Tap the brakes

BUZZ-U.S. stocks weekly: Tap the brakes ** S&P 500 .SPX snaps six-week winning streak, loses 1% as corporate reports pour in .N ** This as the benchmark index sees another spooky turn ** Dow .DJI also ends six-week string of gains, though Nasdaq Composite .IXIC extends its winning streak to seven weeks ** With this, the composite finally scores a fresh record intraday high ** Benchmark U.S.
A
B
N
Q
S
T
W
L
T
G
U
U
H
G
U

U.S. BXP, Medpace Holdings, Starbucks

U.S. RESEARCH ROUNDUP-BXP, Medpace Holdings, Starbucks Oct 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including BXP, Medpace Holdings and Starbucks, on Wednesday. HIGHLIGHTS * BXP Inc BXP.N : Piper Sandler raises to overweight from neutral * Danaher Corp DHR.N : TD Cowen raises target price to $315 from $310 * Medpace Holdings Inc MEDP.O : Jefferies cuts target price to $305 from $345 * Starbucks SBUX.O : Stifel cuts ta
I
M
P
S
Z
S
G
I

U.S. STOCKS Freeport-McMoRan, A.O. Smith, Genuine Parts

BUZZ-U.S. STOCKS ON THE MOVE-Freeport-McMoRan, A.O. Smith, Genuine Parts Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes slipped on Tuesday as rising Treasury yields impacted rate-sensitive sectors, while investors continued to evaluate earnings to assess the health of American companies.
B
C
P
S
Z
U
U
S
W
A
G

Genuine Parts tumbles 20%, tracking record drop on weak forecast, earnings miss

BUZZ-Genuine Parts tumbles 20%, tracking record drop on weak forecast, earnings miss Updates with milestones, changes headline ** Shares of automotive and industrial spare parts maker Genuine Parts Company GPC.N down 20% at $114.80 on Tues and on course for biggest daily drop ever after annual forecast cut, profit miss ** Stock hits lowest levels since Mar 2021 and is easily biggest S&P 500 ** GPC lowers FY profit forecast to $8.00 - $8.20 from prior forecast of $9.30 to $9.50 per share ** Co re
U
G

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.